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Formation of tissue barriers by epithelial and endothelial cells requires neighbouring cells to interact 
via intercellular junctions, which includes tight junctions. Tight junctions form a semipermeable 
paracellular diffusion barrier and act as signalling hubs that guide cell behaviour and differentiation. 
Components of tight junctions are also expressed in cell types not forming tight junctions, such as 
cardiomyocytes, where they associate with facia adherens and/or gap junctions. This review will focus 
on tight junction proteins expressed in epithelial and endothelial cells, and their importance in tissue 
homeostasis and remodelling with a particular emphasis on what we have learned from animal models 




 Cells interact with their neighbours and the underlying extracellular matrix via specialized protein 
complexes that mediate adhesion, maintain structure and transmit information to the cell interior about 
the environment. This information is essential for different aspects of tissue functions as well as for 
physiological and pathological remodelling. At the lateral membrane of epithelia and endothelia, 
junctional complexes include tight junctions (TJ) and adherens junctions (AJs), two adhesion 
complexes that are structurally and functionally intertwined (Fig. 1). TJ form regulatable 
semipermeable paracellular barriers that control paracellular diffusion of solutes according to size and 
charge, and function as fences that restrict lipid diffusion between the apical and basolateral 
membrane domains (Fig. 2). TJ also act as signalling hubs that guide epithelial proliferation, death, 
polarisation and differentiation. TJ-associated transmembrane proteins interact with different 
components of the TJ-associated cytoplasmic plaque. Although not fully understood,  these 
interactions result in a protein network that controls multiple cell functions involved in tissue 
remodelling such as junctional dynamics, cell migration, proliferation and gene expression. TJ 
structure, composition and function have recently been reviewed [1,2]. Here, we will focus on TJ and 
their contributions to tissue remodelling with an emphasis on transmembrane proteins and 
RhoGTPase signalling. 
 
Transmembrane proteins of TJ 
 TJ contain a complex set of transmembrane proteins that includes the tetraspan proteins of the 
claudin family and occludin-related Marvel domain porteins, as well as multiple adhesion proteins with 
immunoglobulin like domains. In vitro and in vivo studies have linked these proteins to different types 
of physiological and pathological examples of tissue remodeling (Table 1).   
 
Marvel domain proteins 
 TJ  contain three Marvel domain proteins: occludin, tricellulin or MarvelD2, and MarvelD3. MARVEL 
domains are motifs based on four transmembrane helices and are found in proteins involved in 
membrane-membrane aposition. Although the three proteins are related, they have distinct functions. 
Occludin knockout mice have a complex phenotype, which includes hyperplasia and chronic 
inflammation of the gastric epithelium, calcification in the brain, testicular atrophy, loss of cytoplasmic 
granules in striated duct cells of the salivary gland, and thinning of compact bones. The underlying 
mechanisms are not known. However, manipulation of occludin in culture affects the junctional barrier 
functions with its N-terminal domain being important for the regulation of neutrophil transmigration. 
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Occludin depletion also inhibits Rho activation required for extrusion of apoptotic cells from 
monolayers. It is thus possible that defects in leukocyte transmigration and cell extrusion lead to 
chronic inflammation and hyperplasia of epithelial tissues in vivo.   
 Occludin depletion leads to junctional remodelling with tricellulin, normally concentrated at tricellular 
corners, becoming more equally distributed along the cell periphery. Tricelllulin is essential for sealing 
tricellular corners and for hearing in human and mice; hence, occludin deficiency in mice also leads to 
deafness as the normal tricellulin localization is disrupted in the hair cells of the inner ear [3]. The 
underlying mechanisms are not well understood. However, tricellulin has recently been shown to 
regulate RhoGTPase signalling by recruiting the guanine-nucleotide-exchange factor (GEF) Tuba 
(ARHGEF36) and, thereby, modulating Cdc42 activation and tension generated at tricellular 
corners[4]. Whether the Tuba/tricellulin interaction is indeed related to hair cell degeneration and 
deafness is unknown.  
 The third Marvel protein, MarvelD3 regulates cell migration and proliferation in cells in culture, and 
MarvelD3 overexpression in pancreatic cancer cells inhibits tumour growth in vivo in mouse 
xenographs [5]. MarvelD3 modulates JNK activation by inhibiting MEKK1, an upstream component of 
the JNK pathway. This regulatory function is also important during osmotic stress-induced cytoskeletal 
remodelling, as MarvelD3-mediated tuning of JNK signalling is required to maintain junctional integrity 
and support cell survival. Further studies will need to address the role of MarvelD3 in tissue 
remodelling in vivo. 
 
Claudins 
 Claudins are part of the paracellular diffusion barrier and mediate ion-selective paracellular 
diffusion by constituting conductive paracellular pores [6]. Knockout studies in mice support this role 
and report phenotypes related to barrier formation and paracellular ion diffusion. Barrier defects often 
lead to inflammatory responses and, consequently, tissue remodelling. Examples include knockouts of 
claudin-2, which leads to increased colorectal inflammation and gallstones; claudin-4, which provokes 
acute lung inflammation; and claudin-7, which induces intestinal inflammatory remodelling (Table 1) 
[7-9]. Given the barrier defects, however, it is generally assumed that the inflammation is an indirect 
response caused by increased tissue permeability rather than reflecting a direct role in inflammatory 
signalling. An exception is claudin-18. Although its deletion also leads to lung remodelling, it is also 
required to activate NF-kB in response to RANKL-stimulated osteoclast differentiation [4,10-12]  
 A different example is provided by claudin-1. Claudin-1 (-/-) mice have an abnormal skin structure 
and function. Claudin-1 is expressed in the stratum granulosum of the skin and skin remodelling is 
though to be due to changes in stratum granulosum composition, leading to aberrant stratum corneum 
structure and barrier function [13]. In humans, claudin-1 has been linked to ichthyosis and neonatal 
sclerosing cholangitis, diseases with skin and liver defects. The molecular mechanisms involved 
remain to be determined. 
 
 JAMs 
 JAMs are adhesion proteins with immunoglobulin like domains and have been linked to 
inflammation, angiogenesis and atherosclerosis. For example, the colonic mucosa of JAM-A-deficient 
mice shows increased claudin-10 and -15 expression, increased paracellular permeability, leukocyte 
infiltration and lymphoid aggregates, and, consequently, these mice are more susceptible to 
experimentally induced colitis [14]. In endothelia, JAM-A regulates angiogenesis and recruitment of 
monocytes to injured vessel walls, a process linked to atherosclerosis [15-17]. Thus, JAM-A seems to 
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be involved in different signalling pathways and process involved in epithelial and endothelial 
remodelling but the responsible molecular mechanism(s) are not well understood.  
 The coxsackievirus and adenovirus receptor (CAR) belongs to the JAM superfamily and functions 
in the pathogenesis of coxsackievirus infection in vivo [18]. CAR is associated with heart intercalated 
disc adherens junctions, as well as lymphatic and epithelial TJ. CAR is essential for normal cardiac 
development, regulates proliferation and differentiation of cardiomyocytes, and adhesion of lymphatic 
endothelial cells [19]. Studies with postnatal mice further revealed that complex formation of CAR with 
connexin 45 is essential for electrical conduction between atrium and ventricle, and normal levels 
beta-catenin and ZO-1 at heart intercalated discs. Thus, junctional adhesion molecules perform 
essential functions in different cell types and can form functional complexes with other junctional 
proteins. 
 
The cytoplasmic plaque 
 The TJ transmembrane proteins interact with a cytoplasmic plaque that links them to the 
cytoskeleton and signalling mechanisms that guide junction assembly and regulate cell behaviour. The 
cytoplasmic plaque is formed by multiple adaptor and scaffolding proteins (e.g., ZO-1/2/3); different 
types of signalling components such as GTP-binding proteins, protein kinases and phosphatases; as 
well as transcriptional and post-transcriptional regulators [20,21]. Several of the TJ associated plaque 
proteins exhibit dual localization at TJs and in the nucleus (e.g. ZONAB, cdk4, symplekin, ZO-2, YAP) 
linking TJ to the regulation of cell proliferation and gene expression. How cytoplasmic plaque proteins 
interact with transmembrane TJ proteins and how these interactions result in the control of TJ 
functions is not well understood; hence, we will only make occasional reference to transmembrane 
proteins when functionally relevant interactions are known.  
  
Rho GTPases and actomyosin regulation 
 Tissue remodeling and TJ have been linked to regulators of Rho signalling involved in actin 
organisation, cell proliferation, gene expression and differentiation[22-24]. We are starting to 
understand how different GEFs and GAPs (GTPase-activating proteins) for different monomeric 
GTPases affect tissue remodelling, and are recruited and regulated by junctional adaptor proteins. 
 RhoA signalling - Three RhoA GEFs have been linked to TJ: ARHGEF2, 11 and 18. 
ARHGEF2/GEF-H1/Lfc regulates  cell proliferation and cytoskeletal remodelling induced by different 
signalling pathways [25-27]. GEF-H1/Lfc interacts with cingulin, a junctional adaptor, which inhibits the 
GEF by junctional sequestration and, thereby, attenuates cell proliferation. JACOP/paracingulin, a 
close relative of cingulin, seems to work redundantly in GEF-H1 regulation. GEF-H1 is inactive at TJ 
and, if activated in response growth factors or cell stress, mediates activation of RhoA signalling 
throughout the cell and activation of ZONAB, a multifunctional protein that regulates transcriptional 
and posttranscriptional gene expression and, thereby, cell proliferation and survival [28,29]. In 
contrast, p114RhoGEF/ARHGEF18 is active at TJ and forms a complex with myosin II, Rock II and 
cingulin to drive junctional RhoA signalling and actomyosin contractility [30]. Its activity is hence 
important for a range of dynamic processes including junction assembly, migration of epithelial sheets 
and tumour cell invasion, as well as epithelial 3D morphogenesis [30,31]. p114RhoGEF also binds 
Lulu2, which is thought to be important during epithelial morphogenesis and apical constriction [32]. 
The third junctional RhoA GEF is ARHGEF11/PDZ-RhoGEF and is recruited to TJ by ZO-1 [33]. 
ARHGEF11 has recently been linked to insulin signalling in mice, suggesting that it may link TJ to 
regulation of metabolic pathways [34].  
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 Rac and Cdc42 signalling - TJs have been also linked to regulation of Rac and Cdc42. Tuba, a 
Cdc42 GEF, interacts with ZO-1 and tricellulin; and Tuba depletion alters the configuration of cell 
junctions, resulting in a curved and slack appearance [4].  Tuba depletion leads to multilumen 
formation and defective spindle orientation in 3D cultures [35]. However, it has not known whether this 
reflects junctional Tuba functions. JACOP/ paracingulin not only interacts with GEF-H1 but also 
Tiam1, a Rac GEF, influencing actin remodelling during junctional assembly [36]. Junctional 
accumulation of cingulin and JACOP are also required for downregulation of Rac1 activity through the 
recruitment of MgcRacGAP [37]. Another junctional GAP important for Rac and Cdc42 signalling is 
SH3BP1, which is important for spatial control of Cdc42 activity [31]. SH3BP1 forms a complex with 
JACOP, CD2AP, and Capz, an actin capping protein, resulting in the formation of a dual activity 




 ZO-1 is a core TJ protein that binds to many cytosolic and transmembrane components, as well as 
F-actin [38]. The importance ZO-1 for the actomyosin cytoskeleton in epithelial cells remains 
controversial, as depletion has been linked to both increased and decreased junctional actomyosin 
[39]. Similarly, conflicting results have been reported for the importance of ZO-1 for junction formation 
and epithelial morphogenesis [39-41]. The effects seem to depend on the cell types analysed, and the 
level and method of downregulation (i.e., knockdown versus knockout, constitutive versus conditional 
depletion) [39,40]. As these in vitro experiments do not yet allow a firm conclusion about the role of 
ZO-1, it has been proposed that ZO-1 and its close homologue ZO-2 function redundantly. However, 
this is not compatible with in vivo experiments demonstrating that ZO-1 and ZO-2 are independently 
essential for normal embryonic development.  
 ZO-1-deficient embryos have defects in vascular development in the yolk sac, and the molecular 
mechanisms by which ZO-1 regulates endothelial junction formation and angiogenic remodelling is 
starting to be understood.  ZO-1 depletion in primary endothelial cell cultures induces stress fibres and 
Rho activation along the basal membrane, leading to reduced tension on VE-cadherin-based 
adherens junctions, reduced cell migration, and defective barrier formation [41]. In vivo, this results in 
inhibition of FGF-2-induced angiogenesis. An important role of ZO-1 is the spatial organisation of 
tension acting on sites of adhesion. Its depletion leads to a redistribution of active myosin II and 
mechanotransducers like vinculin from junctions to stress fibres and focal adhesions, respectively. The 
redistribution of mechanotransducers is ROCK-dependent and can be phenocopied by JAM-A, 
JACOP, or p114RhoGEF (ARHGEF18) down-regulation [41]. It thus seems that ZO-1 regulates 
junction formation by stimulating RhoA-activated junctional tension to balance tension generated along 
the basal membrane. Such a role for ZO-1 is also supported by the function of its homologue in C. 
elegans, zoo-1, which is required during elongation to prevent rupture of epidermal cell-cell junctions 
[42]. Similarly, the Drosophila homologue Polychaetoid localizes at AJ and regulates embryonic 
morphogenesis by regulating the actin cytoskeleton [43]. 
 
Cell polarity and apical differentiation 
 TJ-associated signalling mechanisms are important drivers of cell polarisation. The TJ polarity 
complexes were original identified in Drosophila (Crumbs/Pals1/Patj) and C. elegans 
(Par3/Par6/atypical PKC). The evolutionarily conserved Rac/Cdc42 effector PAR3/PAR6/aPKC 
complex is required for the formation of distinct tight and adherens junctions, and epithelial and 
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endothelial morphogenesis in tissue culture [44,45]. These in vitro data are supported by in vivo 
studies, demonstrating that Par3 knockout in mice results in defective apical remodelling in epicardial 
cysts during cardiac morphogenesis. The PAR3/PAR6/aPKC complex cooperates with the Crumbs 
complex to guide apical polarisation. Of the three vertebrate Crumbs homologues, Crb3 is expressed 
in epithelia and associated with TJ. Deletion of Crb3 in mouse leads to death after birth and 
pathological remodelling in the kidney, lungs and intestine. It is thought that these defects are due to 
the role of Crb3 in polarity signalling, modulation of the cytoskeleton via associated proteins such as 
ezrin [46], and by coupling cell density sensing to Hippo-dependent control of the TGF-β-SMAD 
pathway [47]. Regulation of Cdc42 is tightly controlled during this process by two junctional GEFs: 
Ect2 stimulating Cdc42 activation during junction formation; and, once junctions have formed, Dbl3, 
which is recruited by ezrin to the apical pole, driving polar Cdc42 activation and apical morphogenesis 
[48].  
 In endothelia, the RhoA GEF Syx has been linked to the Crumbs complex and junction formation in 
mice and zebrafish. Syx is recruited to junctions by Mupp1, a close relative of Patj and part of the 
Crumbs polarity complex, and promotes junction integrity by activating the RhoA effector Diaphanous. 
Localization of Syx is regulated by two antagonistic mechanisms: VEGF causes translocation of Syx 
from cell junctions and Ang1 stabilises Syx at the junction [49]. Syx redistribution requires the Rab 
GTPase Rab13, which is in agreement with Rab13 knockdown experiments in zebrafish that revealed 
a role of the GTPase vessel sprouting [50].  
 
Concluding Remarks 
 A multitude of TJ proteins have been identified and information about their functional properties is 
starting to become available. However, how the different junctional components cooperate to regulate 
the complex processes underlying cell dynamics and tissue remodelling is still poorly understood. This 
is best illustrated in the gap of knowledge about how transmembrane proteins regulate and are 
regulated by the cytoplasmic plaque. To fill such gaps will not only require detailed molecular and 
structural work using different model systems in vitro, it will also require more detailed in vivo studies 
that make use of cell type-specific inactivation of genes in different model organisms and to analyse 
such models under distinct physiological and pathological conditions combined with an analysis of the 
induced changes on a molecular, cellular, tissue, and organ level. Another emerging research area 
relevant for tissue remodeling is to disclose the molecalur mechanisms involved in the cross-talk 
between tight junctions with other cell-cell and extracellular adhesion complexes and how such 
processes coordinate dynamic remodeling of adhesion complexes. 
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Figure 1. Intercellular junctions in epithelia, endothelia and cardiomyocytes.  
Schematic representation of main intercellular junctions in vertebrate cell types discussed in this 
review. Epithelia and endothelia form tight and adherens junctions that are often closely associated 
and linked to the actin cytoskeleton. Mature tight and adherens junctions are morphologically and 
biochemically distinct but form from a primordial junction that contains tight and adherens junctions. In 
epithelia, tight junctions generally form the apical/lateral border and, hence, are localized more apically 
than adherens junctions. In endothelia, the two junctions can be intercalated. Cardiomyocytes do not 
form tight junctions but form a variant of adherens junctions, fascia adherens junctions, that also 
contains proteins associated with tight junctions in epithelia. Gap junctions, which form small channels 
allowing cell-cell communication, are expressed in all three cell types and also recruite tight junction 
proteins in some cell types. Epithelia and cardiomyocites also form desmosomes that link the 
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Figure 2. Composition and function of tight junctions.  
Tight junctions are formed by a heterogenous set of transmembrane proteins that includes the 
tetraspan proteins of the claudin family and three Marvel domain proteins, as well as BVES, adhesion 
proteins with immunoglobulin-like domains, and the polarity signalling protein Crb3. These 
transmembrane proteins interact with a complex protein web, the cytoplasmic plaque, formed by 
scaffolding and signalling proteins that links the junction to the actin cytoskeleton. Tight junctions have 
three main functions. Firstly, they form paracellular diffusion barriers that enable epithelia and 
endothelia to form tissue barriers; these barriers are semipermeable and allow size- and ion-selective 
paracellular diffusion of solutes. Secondly, tight junctions form an intramembrane diffusion barrier that 
restricts the intermixing of apical and lateral plasma membrane components. Thirdly, tight junctions 
contain a complex set of signalling proteins that are components of regulatory mechanisms that guide 
cell behaviour and differentiation. Note, only proteins discussed in this review are indicated.  
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